Tag: Iovance Biotherapeutics breakthrough

Home / Iovance Biotherapeutics breakthrough

Categories

Lifileucel is approved by the USFDA for unresectable or metastatic melanoma

The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or met...
iovance-biotherapeutics-breakthrough

Scan the code